Endocrine and Anthropometric Biomarker Patterns in Iraqi Women With Idiopathic Premature Ovarian Insufficiency: A Case-Control Study
Keywords:
Premature Ovarian Insufficiency; Follicle-stimulating Hormone; Estradiol; Luteinizing Hormone; Dehydroepiandrosterone SulfateAbstract
Background: Premature ovarian insufficiency is characterized by impaired ovarian function before the age of 40 years and is associated with reproductive, skeletal, cardiovascular, and metabolic consequences. broader endocrine profiling may provide additional insight into the hormonal phenotype of idiopathic POI. This study compared reproductive and adrenal hormone profiles and anthropometric indices between Iraqi women with idiopathic premature ovarian insufficiency and healthy controls of comparable reproductive age, and explored associations among endocrine and anthropometric variables. Materials and Methods: In this case-control study, 100 women were enrolled, including 50 women with idiopathic premature ovarian insufficiency and 50 healthy controls of comparable reproductive age with regular menstrual cycles. Serum follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, testosterone, and dehydroepiandrosterone sulfate were measured, together with body mass index and waist circumference. Group differences were assessed using independent-sample tests. Correlations were evaluated using Pearson correlation analysis, and multivariable linear regression was used to identify hormonal predictors of estradiol concentrations. Receiver operating characteristic curve analysis was performed exploratorily. Results: Women with premature ovarian insufficiency had significantly higher follicle-stimulating hormone, luteinizing hormone, progesterone, and dehydroepiandrosterone sulfate concentrations and significantly lower estradiol and testosterone concentrations than controls. Follicle-stimulating hormone was strongly positively correlated with luteinizing hormone and strongly inversely correlated with estradiol. In multivariable regression, follicle-stimulating hormone remained the strongest inverse predictor of estradiol concentration. Exploratory ROC analysis showed complete separation between groups for several biomarkers; however, these findings should be interpreted cautiously because follicle-stimulating hormone was part of the diagnostic case definition. Conclusion: Idiopathic premature ovarian insufficiency in this Iraqi cohort was characterized by marked disruption of the hypothalamic–pituitary–ovarian axis, reflected by elevated gonadotropins and reduced estradiol. Increased dehydroepiandrosterone sulfate may indicate altered adrenal–ovarian endocrine interaction. Future studies should use non-circular biomarker validation designs and adjust for potential metabolic and endocrine confounders.
References
Panay N, Anderson RA, Bennie A, Cedars M, Davies M, Ee C, et al. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open. 2024;2024(4):hoae065.
https://doi.org/10.1093/hropen/hoae065
PMid:39660328 PMCid:PMC11631070
Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-937.
https://doi.org/10.1093/humrep/dew027
PMid:27008889
Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis: the TRIPOD statement. Ann Intern Med. 2015;162(1):55-63.
https://doi.org/10.7326/M14-0697
PMid:25560714
Rutjes AWS, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PMM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51(8):1335-1341.
https://doi.org/10.1373/clinchem.2005.048595
PMid:15961549
Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606.
Vincent AJ. Premature ovarian insufficiency: recommendations from new guidelines. Medicine Today. 2025;26(9):15-22.
Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588-1599.
https://doi.org/10.1016/j.fertnstert.2016.09.046
PMid:27912889 PMCid:PMC5137796
Bidet M, Bachelot A, Bissauge E, Golmard JL, Gricourt S, Dulon J, et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab. 2018;103(10):3864-3872.
https://doi.org/10.1210/jc.2011-1038
PMid:21994953
Soman M, Huang LC, Cai WH, Xu JB, Chen JY, He RK, et al. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. Menopause. 2019;26(1):78-93.
https://doi.org/10.1097/GME.0000000000001161
PMid:29994966 PMCid:PMC6314630
Qin Y, Jiao X, Simpson JL, Chen ZJ. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 2019;25(6):787-808.
https://doi.org/10.1093/humupd/dmv036
PMid:26243799 PMCid:PMC4594617
Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic autoimmunity in young women with spontaneous premature ovarian failure. Hum Reprod. 2017;32(5):1116-1122.
Roeters van Lennep JE, Heida KY, Bots ML, Hoek A; Dutch Multidisciplinary Guideline Development Group. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25(12):1282-1291.
Gulhan I, Bozkaya G, Uyar I, Oztekin D, Pamuk BO, Dogan E. Serum lipid levels in women with premature ovarian insufficiency. Menopause. 2017;24(8):915-920.
de Kat AC, Dam V, Onland-Moret NC, Eijkemans MJC, Broekmans FJM, van der Schouw YT. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 2017;15:2.
https://doi.org/10.1186/s12916-016-0762-8
PMid:28049531
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
https://doi.org/10.1136/bmj.h5527
PMid:26511519
Hajian-Tilaki K. Receiver operating characteristic curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4(2):627-635.
Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847-3853.
https://doi.org/10.1210/jc.2005-0212
PMid:15827095
Lebbe M, Woodruff TK. Involvement of androgens in ovarian health and disease. Mol Hum Reprod. 2013;19(12):828-837.
https://doi.org/10.1093/molehr/gat065
PMid:24026057 PMCid:PMC3843026
Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. Endotext [Internet]. 2018.
Prior JC. Progesterone for the prevention and treatment of osteoporosis in women. Climacteric. 2018;21(4):366-374.
https://doi.org/10.1080/13697137.2018.1467400
PMid:29962257
Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric. 2016;19(1):27-36.
https://doi.org/10.3109/13697137.2015.1094784
PMid:26576012
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.





